RNTX | NASDAQ

Rein Therapeutics, Inc.

Rein Therapeutics, Inc. (RNTX) | runway 4.3 months | financing risk high | market cap $40.7M. Daily snapshot of financials, capital pressure, and recent deve...

Company websiteLast updated Apr 29, 2026

Share price

$1.28

As of Apr 29, 2026

Market cap

$40.7M

Snapshot valuation

30D volume

148,641 shares

Rolling average daily volume

Runway

4.3 months

Estimated from precomputed burn and cash

Financing risk

N/A

The company screens as likely to return to the capital markets soon.

Snapshot summary

Runway: 4.3 months based on estimated burn.

Recent financing detected on Apr 27, 2026.

Financing signal: The company screens as likely to return to the capital markets soon.

Recent developments

Rein Therapeutics, Inc. S-1 2026-04-28

S-1 filing submitted on 2026-04-28.

Apr 27, 2026, 8:00 PM

Rein Therapeutics, Inc. 10-K 2026-03-26

10-K filed on 2026-03-26.

Mar 25, 2026, 8:00 PM

Rein Therapeutics, Inc. 8-K 2026-03-02

8-K filed on 2026-03-02.

Mar 1, 2026, 7:00 PM

Rein Therapeutics, Inc. 8-K 2026-02-19

8-K filed on 2026-02-19.

Feb 18, 2026, 7:00 PM

Rein Therapeutics, Inc. 8-K 2026-01-16

8-K filed on 2026-01-16.

Jan 15, 2026, 7:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures